NCT05218681

Brief Summary

The purpose is to measure substance use disorder (SUD)-related stigma among hospital-based nurses using validated survey instruments, and attempt to reduce stigma through a combination of individual and unit-based educational and participatory interventions.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
170

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Nov 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 15, 2021

Completed
2 days until next milestone

Study Start

First participant enrolled

November 17, 2021

Completed
3 months until next milestone

First Posted

Study publicly available on registry

February 1, 2022

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 8, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 8, 2022

Completed
Last Updated

September 9, 2022

Status Verified

September 1, 2022

Enrollment Period

9 months

First QC Date

November 15, 2021

Last Update Submit

September 7, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in stigma towards patients with Substance use disorder on the individual nursing level

    Change in stigma towards patients with substance use disorder based on pre-post survey among individual nurses. Nurses will be given the same survey pre and post-intervention. The survey includes a Modified stigma score where likert scales are dichotomized as follows: * Very Approriate, Appropriate vs Other * Strongly agree and agree vs other

    6-months

Secondary Outcomes (1)

  • Change in stigma on the unit-level

    6-months

Study Arms (2)

Control: Unit-based "Person First" Anti-stigma Awareness Rounds

OTHER

The "Person First" Initiative was developed independent of this study by bedside nurses (including McFadden) in collaboration with HUP Nursing Executive Leadership. The objective of this initiative is to provide (1) unit-based "huddles" on person-first language as a mechanism to reduce the stigma around substance use; (2) socialize best practices and resources for patients with substance use disorder; and (3) provide overdose reversal training and kits, including Narcan nasal spray, to nurses. The planning and implementation of these activities fall under the purview of Nursing Shared Governance (NOT the research team), and oversight for these activities will be provided by HUP Nursing Executive Leadership.

Other: Unit-based "Person First" Anti-stigma Awareness Rounds

Unit-based "Person First" stigma rounds + Text-based Messaging

OTHER

Participating nurses will be randomized to receive weekly short text messages that employ evidence-based strategies to reduce stigma towards individuals with substance use disorder over the course of 6-months.

Other: Unit-based "Person First" Anti-stigma Awareness RoundsOther: Individual Text-based Messaging

Interventions

Educational rounds on stigma

Control: Unit-based "Person First" Anti-stigma Awareness RoundsUnit-based "Person First" stigma rounds + Text-based Messaging

Weekly evidence based messages to reduce SUD stigma

Unit-based "Person First" stigma rounds + Text-based Messaging

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Registered nurses working in any capacity (bedside, administration) at the Hospital of the University of Pennsylvania.

You may not qualify if:

  • If a nursing leadership on a unit declines survey participation for their unit, nurses who work on that unit will not be recruited/included.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Pennsylvania

Philadelphia, Pennsylvania, 19104, United States

Location

MeSH Terms

Conditions

Substance-Related DisordersSocial Stigma

Condition Hierarchy (Ancestors)

Chemically-Induced DisordersMental DisordersSocial BehaviorBehavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor of Emergency Medicine and Epidemiology

Study Record Dates

First Submitted

November 15, 2021

First Posted

February 1, 2022

Study Start

November 17, 2021

Primary Completion

August 8, 2022

Study Completion

August 8, 2022

Last Updated

September 9, 2022

Record last verified: 2022-09

Locations